Grant 1: Validating Protein Pathway Information – Integrating Proteomic Data with Transcriptomic or Metabolomic Datasets.
Grant 2: Modeling Disease Progression – Combining Gene Expression and Copy Number Variation Data.
The awards are open to principal investigators in foreign and domestic academic institutions and non-profit organizations. The submission deadline for these two grants is Aug. 12. Grant awards will be announced Sept. 30.
For more information or to apply, visit http://www.agilent.com/lifesciences/emerginginsights.
About Agilent Technologies
Agilent Technologies Inc. (NYSE: A) is the world’s premier measurement company and a technology leader in chemical analysis, life sciences, electronics and communications. The company’s 18,500 employees serve customers in more than 100 countries. Agilent had net revenues of $5.4 billion in fiscal 2010. Information about Agilent is available at www.agilent.com.
Further technology, corporate citizenship and executive news is available at www.agilent.com/go/news
Louise Muttram
Account Manager
dna medical communications
Fox Court, 14 Grays Inn Road
London, WC1X 8WS
United Kingdom
T:+44 (0)20 7067 0216
F:+44 (0)844 826 8317
LMuttram@dnamedcomms.com
